Safety, Tolerability and Immunogenicity of HPV (Human Papilloma Virus) Vaccine in Healthy Females 9 to 15 Years of Age in India (V501-029)
Clinical trial NCT00380367 · COMPLETED
Trial details
- NCT number
- NCT00380367
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-05-03
- Primary completion
- 2008-02-04
- Enrollment
- 110
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.